Gynecology
Commentary
FDA addresses unmet need in drug development guidance for female sexual dysfunction
The guidance document acknowledges that there is a medical need for drugs to treat women with sexual dysfunction. It also supports retaining the...
Conference Coverage
Nonsurgical biomarkers show potential in chronic endometriosis
SALT LAKE CITY - Certain nonsurgical biomarkers appear to accurately identify chronic endometriosis and might soon spare patients from years of...
Expert Commentary
Liletta gets a new inserter: Steps for successful placement
The unique cost set-up of Liletta relies on physician uptake, which in turn relies on ease of useA new single-handed inserter (SHI) for placement...
Conference Coverage
Ulipristal acetate meets primary endpoint in pivotal uterine fibroids trial
SALT LAKE CITY
Commentary
Letters to the Editor: Risk-reducing surgery for BRCA mutation carriers
Master Class
VIDEO: The surgical treatment of pelvic congestion
Pelvic congestion syndrome accounts for 30%-70% of cases presenting with chronic pelvic pain and can be caused by pelvic venous insufficiency.
Clinical Review
2016 Update on pelvic floor dysfunction
Options for treating the symptoms of genitourinary syndrome of menopause are expanding. Vaginal estrogen cream, an oral nonestrogen agent (...
Commentary
Letters to the Editor: Extended use IUDs
Medical Education Library
Fostering surgical innovation: The path forward
How do we get past the current “chill” on innovation in gynecologic surgery?
Product Review
Product Update: Kyleena; LapCap2
NEW LNG IUS: GOOD FOR 5 YEARS Kyleena™ (levonorgestrel-releasing intrauterine system; IUS) 19.5 mg, from Bayer, is a new hormonal contraceptive...
From the Journals
Subgroup may benefit from seribantumab for platinum-resistant ovarian cancer
Adding seribantumab to paclitaxel did not extend survival as was hoped in unselected patients with platinum-resistant or refractory ovarian cancer...